Month: September 2018

NORML Endorses Utah’s Proposition 2

The National Organization for the Reform of Marijuana Laws (NORML) endorses Proposition 2: The Utah Medical Cannabis Act, which regulates the licensed production and distribution of medical cannabis products to qualified patients who possess a physician’s recommendation.

Kentucky NORML Newsletter for September 2018

Update from Kentucky NORML: State Interim Joint Judiciary Committee held a meeting to discuss medical marijuana and the bill being proposed by Rep. Nemes (R-), Rep. St. Onge (R-), Rep. Hart (R-) and Rep Sims (D-) and Rep. Jason Nemes, R-Louisville, presents information on proposed legislation on medical marijuana for the 2019 Regular Session of the General Assembly during the Interim Joint Committee on Licensing, Occupations, and Administrative Regulations. Read more in our September Newsletter!

Congressional Committee Approves Legislation To Facilitate Clinical Cannabis Research

Members of the House Judiciary Committee voted today in favor of legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to clinically study marijuana in a manner similar to other controlled substances.

NORML Endorses Michigan’s Proposal 1

The initiative permits those over the age of 21 to possess and grow personal use quantities of cannabis and related concentrates, while also licensing activities related to commercial marijuana production and retail marijuana sales.